ME Therapeutics Holdings Ratios and Metrics

Market cap in millions CAD. Fiscal year is September - August.

Millions CAD. Fiscal year is Sep - Aug.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Feb '25 Feb 21, 2025	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022
Market Capitalization	210	69	-	-
Enterprise Value	208	68	-	-
Last Close Price	8.00	2.75	-	-
PB Ratio	151.86	46.94	-	-
P/TBV Ratio	72.13	46.94	-	-
Debt / Equity Ratio	0.08	-	0.08	-1.46
Quick Ratio	7.70	24.05	4.41	0.57
Current Ratio	8.18	24.45	4.52	0.59
Return on Equity (ROE)	-145.75%	-129.52%	-3327.53%	-
Return on Assets (ROA)	-81.00%	-77.65%	-157.78%	-
Return on Capital (ROIC)	-87.97%	-84.18%	-195.65%	-
Earnings Yield	-0.60%	-1.87%	-	-
FCF Yield	-0.26%	-0.95%	-	-
Buyback Yield / Dilution	-27.71%	-55.90%	-84.08%	-
Total Shareholder Return	-27.71%	-55.90%	-84.08%	-

Source: S&P Capital IQ. Standard template. Financial Sources.